The vascular barrier-protecting hawthorn extract WS 1442 raises endothelial calcium levels by inhibition of SERCA and activation of the IP3 pathway

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 4, 2012, Pages 567-577

  Willer, Elisabeth A ^a   Malli, Roland ^b   Bondarenko, Alexander I ^b   Zahler, Stefan ^a   Vollmar, Angelika M ^a   Graier, Wolfgang F ^b   Fürst, Robert ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Calcium; Crataegus extract; Endothelium

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM ION; CRATAEGUS EXTRACT; HISTAMINE; INOSITOL 1,4,5 TRISPHOSPHATE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; BIOSENSOR; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PATCH CLAMP; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CELLS, CULTURED; ENDOPLASMIC RETICULUM; ENDOTHELIAL CELLS; FLAVONOIDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PATCH-CLAMP TECHNIQUES; PLANT EXTRACTS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-POTASSIUM-EXCHANGING ATPASE;

CRATAEGUS;

EID: 84865537056     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.07.002     Document Type: Article

References (54)

1. Czygan F.C. A short cultural history in retrospect. Crataegus as a cardiac agent. Pharm Unserer Zeit 2005, 34:10-13.
2. Tauchert M. Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure. Am Heart J 2002, 143:910-915.
3. Pittler M.H., Guo R., Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 2008, CD005312.
4. Holubarsch C.J., Colucci W.S., Meinertz T., Gaus W., Tendera M. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Eur J Heart Fail 2008, 10:1255-1263.
5. Müller A., Linke W., Klaus W. Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes. Planta Med 1999, 65:335-339.
6. Schwinger R.H., Pietsch M., Frank K., Brixius K. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently. J Cardiovasc Pharmacol 2000, 35:700-707.
7. Brixius K., Willms S., Napp A., Tossios P., Ladage D., Bloch W., et al. Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 2006, 20:177-184.
8. Anselm E., Socorro V.F., Dal-Ros S., Schott C., Bronner C., Schini-Kerth V.B. Crataegus special extract WS 1442 causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of endothelial NO synthase but not via activation of estrogen receptors. J Cardiovasc Pharmacol 2009, 53:253-260.
9. Galley H.F., Webster N.R. Physiology of the endothelium. Br J Anaesth 2004, 93:105-113.
10. Bubik M.F., Willer E.A., Bihari P., Jurgenliemk G., Ammer H., Krombach F., et al. A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS(R) 1442 targets the cAMP/Rap1 pathway. J Mol Cell Cardiol 2011.
11. Tran Q.K., Watanabe H. Calcium signalling in the endothelium. Handb Exp Pharmacol 2006, 145-187.
12. Tran Q.K., Ohashi K., Watanabe H. Calcium signalling in endothelial cells. Cardiovasc Res 2000, 48:13-22.
13. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
14. Ahmmed G.U., Malik A.B. Functional role of TRPC channels in the regulation of endothelial permeability. Pflugers Arch 2005, 451:131-142.
15. Fürst R., Zahler S., Vollmar A.M. Dexamethasone-induced expression of endothelial mitogen-activated protein kinase phosphatase-1 involves activation of the transcription factors activator protein-1 and 3',5'-cyclic adenosine 5'-monophosphate response element-binding protein and the generation of reactive oxygen species. Endocrinology 2008, 149:3635-3642.
16. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690.
17. 2+ overload. J Cell Sci 2008, 121:3133-3139.
18. 2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci U S A 2004, 101:17404-17409.
19. Bentley M., Nycz D.C., Joglekar A., Fertschai I., Malli R., Graier W.F., et al. Vesicular calcium regulates coat retention, fusogenicity, and size of pre-Golgi intermediates. Mol Biol Cell 2010, 21:1033-1046.
20. Khan M.J., Alam M.R., Waldeck-Weiermair M., Karsten F., Groschner L., Riederer M., et al. Inhibition of autophagy rescues palmitic acid induced necroptosis of endothelial cells. J Biol Chem 2012.
21. Wysolmerski R.B., Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci U S A 1990, 87:16-20.
22. 2+ in toxic cell killing. Trends Pharmacol Sci 1989, 10:281-285.
23. Lingrel J.B., Kuntzweiler T. Na+, K(+)-ATPase. J Biol Chem 1994, 269:19659-19662.
24. Mayol V., Dignat-George F., Gerbi A., Martin-Vasallo P., Lesaule G., Sampol J., et al. Evidence that human endothelial cells express different isoforms of Na, K-ATPase. J Hypertens 1998, 16:145-150.
25. +ATPase is involved in the sustained ACh-induced hyperpolarization of endothelial cells from rat aorta. Br J Pharmacol 2006, 149:958-965.
26. Thomas R.C. Electrogenic sodium pump in nerve and muscle cells. Physiol Rev 1972, 52:563-594.
27. 2+ entry. J Biol Chem 2011, 286:36448-36459.
28. van Nieuw Amerongen G.P., van Hinsbergh V.W. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2002, 39:257-272.
29. 2+]i. Am J Physiol 1999, 276:H1892-H1901.
30. 2+ mediates rac activation and adherens junction assembly in endothelial cells. J Biol Chem 2005, 280:17320-17328.
31. 2+ influx in vascular endothelial cells. J Cell Biochem 2009, 108:499-507.
32. Smyth J.T., Hwang S.Y., Tomita T., DeHaven W.I., Mercer J.C., Putney J.W. Activation and regulation of store-operated calcium entry. J Cell Mol Med 2010, 14:2337-2349.
33. Groschner K., Hingel S., Lintschinger B., Balzer M., Romanin C., Zhu X., et al. Trp proteins form store-operated cation channels in human vascular endothelial cells. FEBS Lett 1998, 437:101-106.
34. DeHaven W.I., Jones B.F., Petranka J.G., Smyth J.T., Tomita T., Bird G.S., et al. TRPC channels function independently of STIM1 and Orai1. J Physiol 2009, 587:2275-2298.
35. 2+ entry function of TRPCs in endothelial cells. Mol Pharmacol 2011.
36. Moore T.M., Brough G.H., Babal P., Kelly J.J., Li M., Stevens T. Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am J Physiol 1998, 275:L574-L582.
37. 2+ influx and endothelial permeability. Am J Physiol Lung Cell Mol Physiol 2004, 287:L1303-L1313.
38. 2+selective, store-operated current (ISOC) in endothelial cell permeability: determinants of the vascular leak site. Circ Res 2005, 96:856-863.
39. Cioffi D.L., Stevens T. Regulation of endothelial cell barrier function by store-operated calcium entry. Microcirculation 2006, 13:709-723.
40. Moore T.M., Norwood N.R., Creighton J.R., Babal P., Brough G.H., Shasby D.M., et al. Receptor-dependent activation of store-operated calcium entry increases endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol 2000, 279:L691-L698.
41. Holda J.R., Blatter L.A. Capacitative calcium entry is inhibited in vascular endothelial cells by disruption of cytoskeletal microfilaments. FEBS Lett 1997, 403:191-196.
42. Wu S., Chen H., Alexeyev M.F., King J.A., Moore T.M., Stevens T., et al. Microtubule motors regulate ISOC activation necessary to increase endothelial cell permeability. J Biol Chem 2007, 282:34801-34808.
43. 2+ channel subunits Orai1 and TRPC1. Biochem Pharmacol 2011, 82:400-410.
44. 2+ uptake by intracellular stores. Pharmacol Ther 1991, 50:191-232.
45. 2+ in human aortic endothelial cells. Eur J Pharmacol 1996, 314:185-192.
46. 2+ exchange in arterial myocytes. Cell Calcium 1997, 21:31-41.
47. Brini M., Carafoli E. The plasma membrane Ca(2)+ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol 2011, 3.
48. 2+ entry in bovine vascular endothelial cells. Cell Calcium 1999, 25:333-343.
49. Strehler E.E., Filoteo A.G., Penniston J.T., Caride A.J. Plasma-membrane Ca(2+) pumps: structural diversity as the basis for functional versatility. Biochem Soc Trans 2007, 35:919-922.
50. Brini M., Carafoli E. Calcium pumps in health and disease. Physiol Rev 2009, 89:1341-1378.
51. 2+ store in A7r5 and 16HBE14o- cells. J Biol Chem 2002, 277:6898-6902.
52. Marin J., Redondo J. Vascular sodium pump: endothelial modulation and alterations in some pathological processes and aging. Pharmacol Ther 1999, 84:249-271.
53. Pittner J., Rhinehart K., Pallone T.L. Ouabain modulation of endothelial calcium signaling in descending vasa recta. Am J Physiol Renal Physiol 2006, 291:F761-F769.
54. Wang Y., Fan R., Gu Y., Adair C.D. Digoxin immune fab protects endothelial cells from ouabain-induced barrier injury. Am J Reprod Immunol 2012, 67:66-72.